Central Drugs Standard Control Organisation (CDSCO) has issued an advisory to state drug regulators.It has asked them to keep monitoring on the manufacture,sale and distribution of buclizine.It is a brand of antihistamine and used as a motion sickness medicine. This advisory came after it was found that a government order prohibiting the sale of buclizine… Continue reading CDSCO asks state drug regulators to ‘keep a strong vigil’ on buclizine sales